[Edaily Reporter Hyera Lee ] NextEye Co., Ltd.(137940)announced on the 15th that “HELACELLONE,” a health functional food made from cultivated wild ginseng roots and sold through the e-commerce platform “ROADMIR,” recently recorded monthly sales of around 2 billion won, growing to an annual sales volume of 20 billion won. NextEye Co., Ltd. CI. (Photo = NextEye Co., Ltd.) Since its launch last December, HELACELLONE has sold more than 10,000 units every month, surpassing cumulative sales of 90,000 units and cumulative revenue of 13.2 billion won in just seven months. NextEye Co., Ltd. explained that although sales are limited to specific quantities depending on raw material supply conditions, the product sells out every month. The product uses 150-year-old cultivated ginseng roots as its main ingredient and sources its raw materials from Wellgreen, which commercialized the cultivation technology developed by a research team at Chungbuk National University. As sales of Heracell One expand, the product lineup on the Roadmir platform is also diversifying. The sales share of the flagship product, “Iona Jin AKG,” has decreased from 85.4% in December of last year to 71.7% in June of this year, while Heracell One has accounted for approximately 10% of monthly sales since its launch. While expanding its cosmetics lineup, NextEye Co., Ltd. plans to sequentially launch new health functional foods and skincare and inner beauty products incorporating complex formulation technology in the second half of the year. A NextEye Co., Ltd. official stated, “We will continue to strengthen the foundation for our platform’s growth by expanding our product portfolio.”
“Via Inkino,” a furniture and lifestyle startup backed by Musinsa Partners, has filed for simplified reorganization with the court. This comes about a year after the company began expanding its busine…
#Harim Industries, a wholly-owned subsidiary of Harim Holdings Co., Ltd., is moving forward with a spin-off to separate its real estate development and food business divisions. This move is seen as a …
SLSBio(Specialty Lab Solution Bio) Co., Ltd(246250)has filed a motion with the court for a provisional injunction to suspend the Korea Exchange’s delisting decision. As a result, the delisting procedu…